» Articles » PMID: 28479296

The Mammalian Malonyl-CoA Synthetase ACSF3 Is Required for Mitochondrial Protein Malonylation and Metabolic Efficiency

Overview
Journal Cell Chem Biol
Publisher Cell Press
Specialty Biochemistry
Date 2017 May 9
PMID 28479296
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Malonyl-coenzyme A (malonyl-CoA) is a central metabolite in mammalian fatty acid biochemistry generated and utilized in the cytoplasm; however, little is known about noncanonical organelle-specific malonyl-CoA metabolism. Intramitochondrial malonyl-CoA is generated by a malonyl-CoA synthetase, ACSF3, which produces malonyl-CoA from malonate, an endogenous competitive inhibitor of succinate dehydrogenase. To determine the metabolic requirement for mitochondrial malonyl-CoA, ACSF3 knockout (KO) cells were generated by CRISPR/Cas-mediated genome editing. ACSF3 KO cells exhibited elevated malonate and impaired mitochondrial metabolism. Unbiased and targeted metabolomics analysis of KO and control cells in the presence or absence of exogenous malonate revealed metabolic changes dependent on either malonate or malonyl-CoA. While ACSF3 was required for the metabolism and therefore detoxification of malonate, ACSF3-derived malonyl-CoA was specifically required for lysine malonylation of mitochondrial proteins. Together, these data describe an essential role for ACSF3 in dictating the metabolic fate of mitochondrial malonate and malonyl-CoA in mammalian metabolism.

Citing Articles

Untargeted Metabolite Profiling Reveals Acute Toxicity of Pentosidine on Adipose Tissue of Rats.

Hu C, Shao Z, Wu W, Wang J Metabolites. 2024; 14(10).

PMID: 39452920 PMC: 11509468. DOI: 10.3390/metabo14100539.


Acetylation, ADP-ribosylation and methylation of malate dehydrogenase.

Kuhn M, Rakus J, Quenet D Essays Biochem. 2024; 68(2):199-212.

PMID: 38994669 PMC: 11451102. DOI: 10.1042/EBC20230080.


An efficient and cost-effective method for disrupting genes in RAW264.7 macrophages using CRISPR-Cas9.

Hossain M, OConnor T PLoS One. 2024; 19(3):e0299513.

PMID: 38483963 PMC: 10939251. DOI: 10.1371/journal.pone.0299513.


NME4 mediates metabolic reprogramming and promotes nonalcoholic fatty liver disease progression.

Xie S, Yuan L, Sui Y, Feng S, Li H, Li X EMBO Rep. 2024; 25(1):378-403.

PMID: 38177901 PMC: 10897415. DOI: 10.1038/s44319-023-00012-6.


Mitochondrial fatty acid synthesis is an emergent central regulator of mammalian oxidative metabolism.

Wedan R, Longenecker J, Nowinski S Cell Metab. 2023; 36(1):36-47.

PMID: 38128528 PMC: 10843818. DOI: 10.1016/j.cmet.2023.11.017.


References
1.
Colak G, Pougovkina O, Dai L, Tan M, Te Brinke H, Huang H . Proteomic and Biochemical Studies of Lysine Malonylation Suggest Its Malonic Aciduria-associated Regulatory Role in Mitochondrial Function and Fatty Acid Oxidation. Mol Cell Proteomics. 2015; 14(11):3056-71. PMC: 4638046. DOI: 10.1074/mcp.M115.048850. View

2.
Zeevalk G, Nicklas W . Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade. J Pharmacol Exp Ther. 1995; 275(3):1124-30. View

3.
Kim Y, Kolattukudy P . Purification and properties of malonyl-CoA decarboxylase from rat liver mitochondria and its immunological comparison with the enzymes from rat brain, heart, and mammary gland. Arch Biochem Biophys. 1978; 190(1):234-46. DOI: 10.1016/0003-9861(78)90273-4. View

4.
Fitzpatrick D, Hill A, Tolmie J, Thorburn D, Christodoulou J . The molecular basis of malonyl-CoA decarboxylase deficiency. Am J Hum Genet. 1999; 65(2):318-26. PMC: 1377930. DOI: 10.1086/302492. View

5.
Wolfgang M, Lane M . The role of hypothalamic malonyl-CoA in energy homeostasis. J Biol Chem. 2006; 281(49):37265-9. DOI: 10.1074/jbc.R600016200. View